Alpha Therapeutic Names Paul A. Foster, M.D. as Vice President, Clinical Research.Business Editors & Health/Medical Writers LOS ANGELES--(BUSINESS WIRE)--May 2, 2000 With an appointment that highlights the continued expansion of its clinical development activities, Alpha Therapeutic Corporation today announced that Paul A. Foster, M.D. has joined the company as Vice President, Clinical Research. In this newly created position, Dr. Foster will be responsible for management of the clinical trials and biostatistical functions necessary to obtain regulatory approval for promising new biological and pharmaceutical therapies under development at Alpha. A board-certified hematologist he·ma·tol·o·gist n. A physician specializing in hematology. Hematologist A medical specialist who treats diseases and disorders of the blood and blood-forming organs. , Dr. Foster has extensive industry experience, most recently as Director, Medical Affairs for the diagnostic division of Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. . He was previously Director, Hemostasis hemostasis /he·mo·sta·sis/ (he?mo-sta´sis) (he-mos´tah-sis) 1. the arrest of bleeding by the physiological properties of vasoconstriction and coagulation or by surgical means. 2. Research and Development at Dade Behring, Inc. and Scientific Director and Medical Co-Director at the Hemostasis Reference Laboratory of the Blood Center of Southeastern Wisconsin. Dr. Foster also served as Associate Medical Director of the Great Lakes Great Lakes, group of five freshwater lakes, central North America, creating a natural border between the United States and Canada and forming the largest body of freshwater in the world, with a combined surface area of c.95,000 sq mi (246,050 sq km). Hemophilia Foundation in Milwaukee, Wisconsin For other places with the same name, see Milwaukee (disambiguation). Milwaukee is the largest city within the state of Wisconsin and 25th largest (by population) in the United States. . He completed his medical training at Duke University Medical Center and also completed a research fellowship in experimental hemostasis at the Research Institute of Scripps Clinic in La Jolla La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , California. "The appointment of Dr. Foster underlies the strong commitment of Alpha to our development program. He is a valuable addition to our management team," said Ralph M. Galustian, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . This product development pipeline includes: enhancements to and new indications for currently licensed biological products derived from human plasma; new plasma products; plasma proteins derived through recombinant technology; and pharmaceutical products including AS-013 for treatment of peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. . "Dr. Foster has a wealth of experience, in industry, medical practice and as a clinical investigator. This knowledge will benefit Alpha as we go forward with our exciting products in development," said James Pennington, M.D., Senior Vice President, Research, Development and Clinical Affairs. Alpha is a leading developer of plasma derived biopharmaceutical products including coagulation factors, immune globulins and plasma volume expanders. Headquartered in Los Angeles, California, the company has over 3,000 employees. Alpha is committed to providing high quality, safe and cost effective therapeutics for improved patient care worldwide. Additional company information is available at www.alphather.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion